Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell GeneDx Holdings Corp (WGS) – GeneDx Holdings Corp Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

GeneDx Holdings (WGS) trades at $50.15, up 4.02% on the day, following a significant 49% price drop in early May 2026 triggered by a major Q1 earnings miss and guidance cut. The technical picture is mixed with a bullish overall signal but bearish moving averages, while fundamentals show strong revenue growth overshadowed by widening net losses and negative profitability metrics. Recent news is dominated by multiple law firm investigations into potential securities fraud following the stock collapse.
The outlook remains challenged by execution risks and negative earnings momentum, though analyst consensus remains overwhelmingly bullish with a $77.50 price target representing 55% upside. Key investment opportunities include accelerating genome test adoption and volume growth, while significant risks include ongoing securities investigations, competitive pressures, and the company's ability to achieve profitability amid rising losses.
Read full analysis

Key Stats

  • Market Cap
    $1.54B
  • Sector
    Technology
  • 3M Drawdown
    -63.49%
  • Enterprise Value
    $1.54B
  • Dividend Yield
    -
  • Trading Activity
    2% Buy | 98% Sell
  • Typical Hold Time
    8 days
$51.99
52W Low: $34.51
05 May 2026
52W High: $167.51
25 Nov 2025

GeneDx Holdings Corp (WGS) is currently valued at a market capitalization of $1.54B, with an enterprise value of $1.54B. Over the past 52 weeks, GeneDx Holdings Corp has traded between a low of $34.51 and a high of $167.51, highlighting its annual price range. Over the past three months, GeneDx Holdings Corp has recorded a drawdown of -63.49%, reflecting recent price volatility. On average, investors hold GeneDx Holdings Corp for approximately 8 days, indicating typical investor behavior on the platform.

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $1.54B
  • Sector
    Technology
  • 3M Drawdown
    -63.49%
  • Enterprise Value
    $1.54B
  • Dividend Yield
    -
  • Trading Activity
    2% Buy | 98% Sell
  • Typical Hold Time
    8 days
$51.99
52W Low: $34.51
05 May 2026
52W High: $167.51
25 Nov 2025

GeneDx Holdings Corp (WGS) is currently valued at a market capitalization of $1.54B, with an enterprise value of $1.54B. Over the past 52 weeks, GeneDx Holdings Corp has traded between a low of $34.51 and a high of $167.51, highlighting its annual price range. Over the past three months, GeneDx Holdings Corp has recorded a drawdown of -63.49%, reflecting recent price volatility. On average, investors hold GeneDx Holdings Corp for approximately 8 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!